Michael Yee
Stock Analyst at UBS
(3.97)
# 1,822
Out of 4,673 analysts
1341
Total ratings
50.8%
Success rate
4.5%
Average return
Main Sectors:
Stocks Rated by Michael Yee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BMY Bristol-Myers Squibb Company | Maintained: Buy | $80 | $67.01 | +19.39% | 6 | Aug 20, 2026 | |
| MRK Merck & Co. | Maintained: Buy | $145 → $175 | $152.55 | +14.72% | 6 | Aug 20, 2026 | |
| VRTX Vertex Pharmaceuticals | Rated: Buy | $585 | $548.05 | +6.74% | 128 | Aug 20, 2026 | |
| MRNA Moderna | Maintained: Hold | $45 → $150 | $145.13 | +3.36% | 71 | Aug 20, 2026 | |
| KOD Kodiak Sciences | Rated: Buy | $80 | $38.33 | +108.71% | 15 | Aug 14, 2026 | |
| TRAX First Tracks Biotherapeutics | Rated: Buy | $65 | $43.11 | +50.78% | 2 | Aug 13, 2026 | |
| DNLI Denali Therapeutics | Rated: Buy | $25 → $34 | $24.92 | +36.44% | 18 | Aug 7, 2026 | |
| AMGN Amgen | Maintained: Buy | $420 → $440 | $439.33 | +0.15% | 187 | Aug 5, 2026 | |
| LLY Eli Lilly and Company | Maintained: Buy | $1,425 | $1,255.40 | +13.51% | 8 | Aug 5, 2026 | |
| RVMD Revolution Medicines | Maintained: Buy | $220 | $209.46 | +5.03% | 7 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $225 → $240 | $216.78 | +10.71% | 172 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $175 | $146.12 | +19.76% | 188 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 → $90 | $66.33 | +35.69% | 6 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $230 → $260 | $264.96 | -1.87% | 6 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $100 → $130 | $107.96 | +20.41% | 7 | Jul 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $76 | $57.74 | +31.62% | 5 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $27 | $28.07 | -3.81% | 8 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $100 → $135 | $134.75 | +0.27% | 6 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 | $21.34 | +110.87% | 1 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $12 | $4.68 | +156.41% | 3 | Jun 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $39.67 | +26.04% | 3 | Jun 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $10.69 | +320.95% | 22 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 | $36.73 | +63.35% | 4 | May 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $2.04 | +194.12% | 13 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $18 → $13 | $19.71 | -34.04% | 18 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 → $20 | $6.67 | +199.85% | 5 | Mar 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $10 → $7 | $6.93 | +1.01% | 10 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $3.78 | +85.19% | 2 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 | $30.82 | +46.01% | 1 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 → $50 | $24.29 | +105.85% | 2 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $50 → $35 | $26.01 | +34.56% | 19 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $50 → $60 | $56.50 | +6.19% | 15 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $2.09 | +282.78% | 4 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $30 → $28 | $29.76 | -5.91% | 5 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 → $55 | $36.88 | +49.13% | 13 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1.5 → $3.5 | $5.30 | n/a | 8 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $32 → $6 | $9.45 | n/a | 48 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 → $18 | $8.29 | n/a | 3 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $145 → $8 | $2.33 | n/a | 6 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3 → $1 | $14.09 | n/a | 34 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 | $54.08 | n/a | 2 | Mar 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $46 → $10 | $0.9965 | n/a | 4 | Dec 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $45 → $15 | $7.52 | n/a | 19 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $10 → $7 | $34.38 | n/a | 8 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 → $31 | $150,000.00 | n/a | 3 | Dec 21, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3.5 | $1.19 | n/a | 1 | Jul 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $5.28 | n/a | 1 | Jul 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.5 → $1 | $3.20 | n/a | 3 | Jul 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $3.41 | n/a | 2 | Oct 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2.5 | $0.0001 | n/a | 2 | Oct 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $116 | $66.70 | n/a | 59 | Sep 25, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $29.50 | n/a | 2 | Sep 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $8.09 | n/a | 1 | Sep 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $45.89 | n/a | 1 | Sep 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $110 | $513.12 | n/a | 43 | Feb 23, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $626 | $834.04 | n/a | 43 | Jan 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $57 | $9.24 | n/a | 9 | Dec 30, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $1.46 | n/a | 1 | Dec 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $113 | $127.81 | n/a | 9 | Nov 14, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $116.64 | n/a | 1 | Oct 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $50.37 | n/a | 1 | Oct 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $133 | $270.24 | n/a | 1 | Oct 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 | $93.35 | n/a | 1 | Oct 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $129 | $329.45 | n/a | 1 | Oct 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $115 | $166.15 | n/a | 1 | Jul 28, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $12 → $2 | $0.000001 | n/a | 5 | Jun 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $85 → $75 | $37.34 | n/a | 7 | Apr 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $15 | $18.79 | n/a | 2 | Feb 5, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $157 | $390.11 | n/a | 1 | Jan 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $193 | $400.54 | n/a | 1 | Jan 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 | $4.18 | n/a | 2 | Jan 4, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $20 | $5.21 | n/a | 8 | Nov 6, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 | $87.11 | n/a | 4 | Aug 5, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $40 | $3.20 | n/a | 4 | Jun 30, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $146.47 | n/a | 1 | Jun 29, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $0.0008 | n/a | 2 | Mar 20, 2012 |
Bristol-Myers Squibb Company
Aug 20, 2026
Maintained: Buy
Price Target: $80
Current: $67.01
Upside: +19.39%
Merck & Co.
Aug 20, 2026
Maintained: Buy
Price Target: $145 → $175
Current: $152.55
Upside: +14.72%
Vertex Pharmaceuticals
Aug 20, 2026
Rated: Buy
Price Target: $585
Current: $548.05
Upside: +6.74%
Moderna
Aug 20, 2026
Maintained: Hold
Price Target: $45 → $150
Current: $145.13
Upside: +3.36%
Kodiak Sciences
Aug 14, 2026
Rated: Buy
Price Target: $80
Current: $38.33
Upside: +108.71%
First Tracks Biotherapeutics
Aug 13, 2026
Rated: Buy
Price Target: $65
Current: $43.11
Upside: +50.78%
Denali Therapeutics
Aug 7, 2026
Rated: Buy
Price Target: $25 → $34
Current: $24.92
Upside: +36.44%
Amgen
Aug 5, 2026
Maintained: Buy
Price Target: $420 → $440
Current: $439.33
Upside: +0.15%
Eli Lilly and Company
Aug 5, 2026
Maintained: Buy
Price Target: $1,425
Current: $1,255.40
Upside: +13.51%
Revolution Medicines
Aug 5, 2026
Maintained: Buy
Price Target: $220
Current: $209.46
Upside: +5.03%
Jul 30, 2026
Maintained: Buy
Price Target: $225 → $240
Current: $216.78
Upside: +10.71%
Jul 28, 2026
Maintained: Buy
Price Target: $175
Current: $146.12
Upside: +19.76%
Jul 24, 2026
Reiterated: Buy
Price Target: $60 → $90
Current: $66.33
Upside: +35.69%
Jul 13, 2026
Rated: Hold
Price Target: $230 → $260
Current: $264.96
Upside: -1.87%
Jul 2, 2026
Rated: Buy
Price Target: $100 → $130
Current: $107.96
Upside: +20.41%
Jun 30, 2026
Maintained: Buy
Price Target: $76
Current: $57.74
Upside: +31.62%
Jun 23, 2026
Maintained: Hold
Price Target: $27
Current: $28.07
Upside: -3.81%
Jun 23, 2026
Downgraded: Hold
Price Target: $100 → $135
Current: $134.75
Upside: +0.27%
Jun 15, 2026
Initiated Coverage: Buy
Price Target: $45
Current: $21.34
Upside: +110.87%
Jun 12, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $4.68
Upside: +156.41%
Jun 9, 2026
Reiterated: Buy
Price Target: $50
Current: $39.67
Upside: +26.04%
Jun 2, 2026
Maintained: Buy
Price Target: $45
Current: $10.69
Upside: +320.95%
May 31, 2026
Maintained: Buy
Price Target: $60
Current: $36.73
Upside: +63.35%
May 12, 2026
Maintained: Buy
Price Target: $6
Current: $2.04
Upside: +194.12%
Mar 17, 2026
Rated: Hold
Price Target: $18 → $13
Current: $19.71
Upside: -34.04%
Mar 5, 2026
Maintained: Buy
Price Target: $3 → $20
Current: $6.67
Upside: +199.85%
Mar 3, 2026
Maintained: Hold
Price Target: $10 → $7
Current: $6.93
Upside: +1.01%
Feb 25, 2026
Maintained: Buy
Price Target: $7
Current: $3.78
Upside: +85.19%
Feb 17, 2026
Initiated Coverage: Buy
Price Target: $45
Current: $30.82
Upside: +46.01%
Jan 7, 2026
Initiated Coverage: Buy
Price Target: $45 → $50
Current: $24.29
Upside: +105.85%
Jan 7, 2026
Initiated Coverage: Buy
Price Target: $50 → $35
Current: $26.01
Upside: +34.56%
Jan 7, 2026
Initiated Coverage: Buy
Price Target: $50 → $60
Current: $56.50
Upside: +6.19%
Jan 6, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $2.09
Upside: +282.78%
Jan 6, 2026
Initiated Coverage: Hold
Price Target: $30 → $28
Current: $29.76
Upside: -5.91%
Jan 6, 2026
Initiated Coverage: Buy
Price Target: $45 → $55
Current: $36.88
Upside: +49.13%
Jun 25, 2025
Maintained: Hold
Price Target: $1.5 → $3.5
Current: $5.30
Upside: n/a
May 27, 2025
Downgraded: Hold
Price Target: $32 → $6
Current: $9.45
Upside: n/a
Mar 13, 2025
Maintained: Buy
Price Target: $24 → $18
Current: $8.29
Upside: n/a
Mar 6, 2025
Maintained: Buy
Price Target: $145 → $8
Current: $2.33
Upside: n/a
Oct 25, 2023
Downgraded: Hold
Price Target: $3 → $1
Current: $14.09
Upside: n/a
Mar 22, 2023
Maintained: Buy
Price Target: $26
Current: $54.08
Upside: n/a
Dec 22, 2021
Downgraded: Hold
Price Target: $46 → $10
Current: $0.9965
Upside: n/a
Aug 10, 2021
Maintained: Hold
Price Target: $45 → $15
Current: $7.52
Upside: n/a
Dec 21, 2020
Maintained: Hold
Price Target: $10 → $7
Current: $34.38
Upside: n/a
Dec 21, 2018
Maintained: Buy
Price Target: $40 → $31
Current: $150,000.00
Upside: n/a
Jul 8, 2018
Reiterated: Hold
Price Target: $3.5
Current: $1.19
Upside: n/a
Jul 8, 2018
Reiterated: Buy
Price Target: $22
Current: $5.28
Upside: n/a
Jul 8, 2018
Reiterated: Hold
Price Target: $1.5 → $1
Current: $3.20
Upside: n/a
Oct 27, 2017
Reiterated: Buy
Price Target: $47
Current: $3.41
Upside: n/a
Oct 2, 2017
Reiterated: Hold
Price Target: $2.5
Current: $0.0001
Upside: n/a
Sep 25, 2017
Reiterated: Buy
Price Target: $116
Current: $66.70
Upside: n/a
Sep 4, 2017
Reiterated: Buy
Price Target: $47
Current: $29.50
Upside: n/a
Sep 4, 2017
Reiterated: Buy
Price Target: $7
Current: $8.09
Upside: n/a
Sep 4, 2017
Reiterated: Buy
Price Target: $5
Current: $45.89
Upside: n/a
Feb 23, 2017
Reiterated: Hold
Price Target: $110
Current: $513.12
Upside: n/a
Jan 3, 2017
Reiterated: Buy
Price Target: $626
Current: $834.04
Upside: n/a
Dec 30, 2016
Reiterated: Hold
Price Target: $57
Current: $9.24
Upside: n/a
Dec 20, 2016
Reiterated: Buy
Price Target: $25
Current: $1.46
Upside: n/a
Nov 14, 2016
Reiterated: Buy
Price Target: $113
Current: $127.81
Upside: n/a
Oct 2, 2016
Reiterated: Buy
Price Target: $48
Current: $116.64
Upside: n/a
Oct 2, 2016
Reiterated: Buy
Price Target: $28
Current: $50.37
Upside: n/a
Oct 2, 2016
Reiterated: Buy
Price Target: $133
Current: $270.24
Upside: n/a
Oct 2, 2016
Reiterated: Buy
Price Target: $95
Current: $93.35
Upside: n/a
Oct 2, 2016
Reiterated: Buy
Price Target: $129
Current: $329.45
Upside: n/a
Jul 28, 2016
Maintained: Buy
Price Target: $115
Current: $166.15
Upside: n/a
Jun 15, 2016
Downgraded: Hold
Price Target: $12 → $2
Current: $0.000001
Upside: n/a
Apr 20, 2016
Reiterated: Buy
Price Target: $85 → $75
Current: $37.34
Upside: n/a
Feb 5, 2016
Reiterated: Hold
Price Target: $15
Current: $18.79
Upside: n/a
Jan 25, 2016
Reiterated: Buy
Price Target: $157
Current: $390.11
Upside: n/a
Jan 25, 2016
Reiterated: Buy
Price Target: $193
Current: $400.54
Upside: n/a
Jan 4, 2016
Reiterated: Hold
Price Target: $7
Current: $4.18
Upside: n/a
Nov 6, 2015
Reiterated: Buy
Price Target: $35 → $20
Current: $5.21
Upside: n/a
Aug 5, 2015
Maintained: Hold
Price Target: $9
Current: $87.11
Upside: n/a
Jun 30, 2014
Rated: Hold
Price Target: $40
Current: $3.20
Upside: n/a
Jun 29, 2012
Upgraded: Buy
Price Target: n/a
Current: $146.47
Upside: n/a
Mar 20, 2012
Maintained: Buy
Price Target: $28
Current: $0.0008
Upside: n/a